VANCOUVER, BC, Nov. 30, 2021 /CNW/ - Numinus Wellness Inc.
("Numinus" or the "Company") (TSXV: NUMI), a mental health care
company advancing innovative treatments and safe, evidence-based
psychedelic-assisted therapies, today announced that it will
participate in the H.C. Wainwright 2nd Annual
Psychedelics Conference to be hosted virtually on Monday, December 6, 2021.
Payton Nyquvest, Founder and CEO
of Numinus, will participate in the Psychedelics Assisted
Psychotherapy panel at 1:30 p.m.
ET. In addition, a corporate presentation by Mr. Nyquvest
will be available on-demand. To attend, register here.
For more information about the conference, or to schedule a
one-on-one meeting with Numinus' management, please contact your
appropriate representative directly, or send an email to H.C.
Wainwright at lk@hcwco.com, or KCSA Strategic Communications at
NuminusIR@kcsa.com.
About Numinus
Numinus Wellness (TSXV: NUMI) helps
people to heal and be well through the development and delivery of
innovative mental health care and access to safe, evidence-based
psychedelic-assisted therapies. The Numinus model – including
psychedelic production, research and clinic care – is at the
forefront of a transformation aimed at healing rather than managing
symptoms for depression, anxiety, trauma, pain and substance use.
At Numinus, we are leading the integration of psychedelic-assisted
therapies into mainstream clinical practice and building the
foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn,
Facebook, Twitter, and Instagram.
Forward-looking statements
This press release
contains forward-looking statements within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs regarding future performance
are "forward-looking statements". Forward-looking statements can be
identified by the use of words such as "expects", "does not
expect", "is expected", , "intends", "anticipates", "does not
anticipate", "believes" or variations of these words, expressions
or statements, that certain actions, events or results "may",
"could", "would", "might" or "will be" taken, will occur or will be
realized. Such forward-looking statements involve risks,
uncertainties and other known and unknown factors that could cause
actual results, events or developments to differ materially from
the results, events or developments expected and expressed or
implied in such forward-looking statements. These risks and
uncertainties include, but are not limited to, dependence on
obtaining and maintaining regulatory approvals, including the
acquisition and renewal of federal, provincial, municipal, local or
other licenses, and any inability to obtain all necessary
government authorizations, licenses and permits to operate and
expand the Company's facilities; regulatory or policy changes such
as changes in applicable laws and regulations, including federal
and provincial legalization, due to fluctuations in public opinion,
industry perception of integrative mental health, including the use
of psychedelic-assisted therapy, delays or inefficiencies or any
other reason; any other factor or development likely to hamper the
growth of the market; the Company's limited operating and
profitability track record; dependence on management; the Company's
need for additional financing and the effects of financial market
conditions and other factors on the availability of capital;
competition, including that of more established and better funded
competitors; the continued impact of the COVID-19 pandemic; and the
need to build and maintain alliances and partnerships, including
with research and development companies, customers and suppliers.
These factors should be carefully considered, and readers are
cautioned not to place undue reliance on forward-looking
statements. Despite the Company's efforts to identify the main risk
factors that could cause actual measures, events or results to
differ materially from those described in forward-looking
statements, other risk factors may cause measures, events or
developments to materially differ from those anticipated, estimated
or intended. There can be no assurance that forward-looking
statements will prove to be accurate, as actual results and future
events could differ materially from those anticipated in
forward-looking statements. The Company does not undertake to
revise forward-looking statements, even if new information becomes
available as a result of future events, new facts or any other
reason, except as required by applicable laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this news release.
View original
content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-hc-wainwright-2nd-annual-psychedelics-virtual-conference-on-december-6th-301433704.html
SOURCE Numinus Wellness Inc.